However, Chase et al. (26) reported reduced growth rates in children with T1DM and subclinical hypothyroidism, particularly in those with TSH levels ≥10 μIU/L, while thyroid hormone replacement therapy led to improved growth only in prepubertal patients. The gene discussed is TG; the disease is hypothyroidism.